共 92 条
[1]
Bubendorf L(2000)Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients Hum Pathol 31 578-583
[2]
Schöpfer A(2001)Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity Clin Chem 47 74-80
[3]
Wagner U(1993)Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation Clin Chem 39 635-640
[4]
Sauter G(2007)Serial markers of bone turnover in men with metastatic prostate cancer treated with zoledronic acid for detection of bone metastases progression Eur Urol 52 1381-1387
[5]
Moch H(2012)Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal-related events in patients with prostate cancer with bone metastasis BJU Int 109 394-400
[6]
Willi N(1988)Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan Cancer 61 195-202
[7]
Janckila AJ(2010)Clinical and imaging correlations of bone turnover markers in prostate cancer patients with bone only metastases Nucl Med Commun 31 249-253
[8]
Takahashi K(2012)Computer-aided diagnosis system for bone scintigrams from Japanese patients: importance of training database Ann Nucl Med 26 622-626
[9]
Sun SZ(2005)Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors J Natl Cancer Inst 97 59-69
[10]
Yam LT(2008)Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid Cancer 113 193-201